Sunday, January 4, 2026 1/4/2026

Role of cholinergic innervation of the liver

Award Number: R01DK134333
ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 12/23/2022
PERIOD OF PERFORMANCE END DATE: 11/30/2026

Group Awards By:

View Award Description

Role of cholinergic innervation of the liver - Studies in this proposal will define the role of this cholinergic innervation of the liver in controlling glucose and lipid metabolism. The dorsal motor nucleus of the vagus (DMV) contains parasympathetic cholinergic neurons. Although there is a contradictory finding of the lack of cholinergic innervation to the mouse liver, prior studies with the retrograde neuronal tracers such as cholera toxin B, pseudorabies virus, and AAV encoding a Cre-inducible reporter protein strongly support that the mouse liver receives DMV cholinergic innervation. Furthermore, we have recently published peer reviewed work demonstrating that hepatocytes receive direct DMV cholinergic input and express muscarinic acetylcholine receptors, suggesting that the hepatic cholinergic system is critical for proper liver function. In our recent studies, optogenetic excitation of cholinergic fibers innervating the liver reduces blood glucose, consistent with the ability of parasympathetic efferent outflow to the liver to suppress hepatic glucose output. Conversely, optogenetic silencing of liver-projecting cholinergic nerves elevates blood glucose levels and also stimulates the expression of key hepatic gluconeogenic genes. As there is no change in plasma glucagon that drives hepatic glucose production, this effect appears to be pancreatic hormone-independent. In contrast to the traditional view that the activation of sympathetic nerves promotes, while the parasympathetic innervation suppresses, hepatic glucose output, our recently published work strongly supports the significant contribution of DMV cholinergic neurons to hepatic glucose output in lean mice. Importantly, our pilot studies reveal that ablation of liver-projecting cholinergic neurons increases hepatic lipolysis and insulin sensitivity in mice fed a high-fat diet. As hepatic gluconeogenesis and intrahepatic lipolysis are closely linked to each other, studies in Aim 1 will identify the necessity of these neurons in the control of ingestive behaviors and hepatic energy metabolism in lean and diet-induced obese mice. Despite the importance of parasympathetic cholinergic neurons to the regulation of hepatic glucose output via both insulin-dependent and -independent ways, it is not known that glucose sensing is an important physiological trigger for this DMV- liver neural circuit. To address this major gap, studies in Aim 2 will determine if glucose-sensing by DMV liver- projecting cholinergic neurons controls cholinergic tone to the liver. While high-fat feeding elevates hepatic sympathetic nerve activity, diet-induced obesity (DIO) reduces action potential firing of parasympathetic motor neurons. Thus, we have begun to probe if the hepatic cholinergic system is subject to modulation by the nutrient status. Our pilot studies reveal that high-fat feeding upregulates Gi-coupled muscarinic acetylcholine receptor type 2 (M2R) and 4 (M4R) expression in the liver. Accordingly, studies in Aim 3 will test the hypothesis that diet-induced alterations in the hepatic cholinergic system disrupt whole- body energy homeostasis and hepatic energy metabolism, causing insulin resistance and hepatic steatosis in DIO.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $505,255 )
2026	2026	ALBERT EINSTEIN COLLEGE OF MEDICINE	1300 MORRIS PARK AVE	BRONX	NY	10461	BRONX	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	4	12/8/2025	NON-COMPETING CONTINUATION	$505,255
														Subtotal = $505,255

Issue Date FY: 2025 ( Subtotal = $505,255 )
2025	2025	ALBERT EINSTEIN COLLEGE OF MEDICINE	1300 MORRIS PARK AVE	BRONX	NY	10461	BRONX	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	3	11/13/2024	NON-COMPETING CONTINUATION	$454,729
2025	2025	ALBERT EINSTEIN COLLEGE OF MEDICINE	1300 MORRIS PARK AVE	BRONX	NY	10461	BRONX	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	001	3	5/21/2025	NON-COMPETING CONTINUATION	$50,526
														Subtotal = $505,255

Issue Date FY: 2024 ( Subtotal = $485,046 )
2024	2024	ALBERT EINSTEIN COLLEGE OF MEDICINE	1300 MORRIS PARK AVE	BRONX	NY	10461	BRONX	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	001	2	5/15/2024	NON-COMPETING CONTINUATION	$30,317
2024	2024	ALBERT EINSTEIN COLLEGE OF MEDICINE	1300 MORRIS PARK AVE	BRONX	NY	10461	BRONX	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	2	11/9/2023	NON-COMPETING CONTINUATION	$454,729
														Subtotal = $485,046

Issue Date FY: 2023 ( Subtotal = $505,255 )
2023	2023	ALBERT EINSTEIN COLLEGE OF MEDICINE	1300 MORRIS PARK AVE	BRONX	NY	10461	BRONX	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	1	12/22/2022	NEW	$505,255
														Subtotal = $505,255

Grand Total All Awards = $2,000,811

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Role of cholinergic innervation of the liver

Award Number: R01DK134333

ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 12/23/2022

PERIOD OF PERFORMANCE END DATE: 11/30/2026

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer